Play all audios:
ABSTRACT The selectivity of microbial inhibitors of acyl-CoA : cholesterol acyltransferase (ACAT) toward the two isozymes, ACAT1 and ACAT2, was assessed in cell-based assays. Purpactin A
(IC50 values of ACAT1 _vs_. IC50 values of ACAT2; 2.5 μM _vs_. 1.5 μM), terpendole C (10 μM _vs_. 10 μM), glisoprenin A (4.3 μM _vs_. 10 μM), spylidone (25 μM _vs_. 5.0 μM) and synthetic
CL-283,546 (0.1 μM _vs_. 0.09 μM) inhibited ACAT1 and ACAT2 to similar extents. Beauveriolides I (0.6 μM _vs_. 20 μM) and III (0.9 μM _vs_. >20 μM) inhibited ACAT1 rather selectively,
while pyripyropenes A (>80 μM _vs_. 0.07 μM), B (48 μM _vs_. 2.0 μM), C (32 μM _vs_. 0.36 μM) and D (38 μM _vs_. 1.5 μM) showed selective inhibition against ACAT2. In particular,
pyripyropene A was found to be the most selective ACAT2 inhibitor with a selective index of more than 1,000. SIMILAR CONTENT BEING VIEWED BY OTHERS MECHANISM OF ACTION FOR SMALL-MOLECULE
INHIBITORS OF TRIACYLGLYCEROL SYNTHESIS Article Open access 29 May 2023 ACYLTRANSFERASE THAT CATALYSES THE CONDENSATION OF POLYKETIDE AND PEPTIDE MOIETIES OF GOADVIONIN HYBRID LIPOPEPTIDES
Article 27 July 2020 CELLUDINONE C, A NEW DIHYDROISOBENZOFURAN ISOLATED FROM _TALAROMYCES CELLULOLYTICUS_ BF-0307 Article 14 November 2024 ARTICLE PDF REFERENCES * Roth BD . ACAT inhibitors:
Evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents. _Drug Disc Today_ 3: 19–25 ( 1998) Article CAS Google Scholar * Alegret M, Llaverias G, Silvestre JS .
Acyl-coenzyme A : cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic agents. _Methods Find Clin Pharmacol_ 26: 563–586 ( 2004) Article CAS Google Scholar *
Chang CC, Huh HY, Cadigan KM, Chang TY . Molecular cloning and functional expression of human acyl-coenzyme A : cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. _J
Biol Chem_ 268: 20747–20755 ( 1993) CAS PubMed Google Scholar * Anderson RA, Joyce C, Davis M, Reagan JW, Clark M, Shelness GS, Rudel LL . Identification of a form of acyl-CoA :
cholesterol acyltransferase specific to liver and intestine in nonhuman primates. _J Biol Chem_ 273: 26747–26754 ( 1998) Article CAS PubMed Google Scholar * Cases S, Novak S, Zheng YW,
Myers HM, Lear SR, Sande E, Welch CB, Lusis AJ, Spencer TA, Krause BR, Erickson SK, Farese RV Jr . ACAT-2, a second mammalian acyl-CoA : cholesterol acyltransferase. Its cloning, expression,
and characterization. _J Biol Chem_ 273: 26755–26764 ( 1998) Article CAS PubMed Google Scholar * Oelkers P, Behari A, Cromley D, Billheimer JT, Sturley SL . Characterization of two
human genes encoding acyl coenzyme A : cholesterol acyltransferase-related enzymes. _J Biol Chem_ 273: 26765–26771 ( 1998) Article CAS PubMed Google Scholar * Parini P, Davis M, Lada AT,
Erickson SK, Wright TL, Gustafsson U, Sahlin S, Einarsson C, Eriksson M, Angelin B, Tomoda H, Ōmura S, Willingham MC, Rudel LL . ACAT2 is localized to hepatocytes and is the major
cholesterol-esterifying enzyme in human liver. _Circulation_ 110: 2017–2023 ( 2004) Article CAS PubMed Google Scholar * Giovannoni MP, Piaz VD, Vergelli C, Barlocco D . Selective ACAT
inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs. _Mini Rev Med Chem_ 3: 576–584 ( 2003) Article CAS PubMed Google Scholar * Lada AT, Davis M,
Kent C, Chapman J, Tomoda H, Ōmura S, Rudel LL . Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. _J Lipid
Res_ 45: 378–386 ( 2004) Article CAS PubMed Google Scholar * Ikenoya M, Yoshinaka Y, Kobayashi H, Kawamine K, Shibuya K, Sato F, Sawanobori K, Watanabe T, Miyazaki A . A selective ACAT-1
inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis: in press ( 2006) * Ōmura S, Tomoda H, Kim YK, Nishida H,
Pyripyropenes highly potent inhibitors of acyl-CoA: cholesterol acyltransferase produced by _Aspergillus fumigatus_. _J Antibiot_ 46: 1168–1169 ( 1993) Article Google Scholar * Tomoda H,
Kim YK, Nishida H, Masuma R, Ōmura S . Pyripyropenes, novel inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Aspergillus fumigatus_. I. Production, isolation, and biological
properties. _J Antibiot_ 47: 148–153 ( 1994) Article CAS Google Scholar * Kim YK, Tomoda H, Nishida H, Sunazuka T, Obata R, Ōmura S . Pyripyropenes, novel inhibitors of acyl-CoA :
cholesterol acyltransferase produced by _Aspergillus fumigatus_. II. Structure elucidation of pyripyropenes A, B, C and D. _J Antibiot_ 47: 154–162 ( 1994) Article CAS Google Scholar *
Tomoda H, Nishida H, Masuma R, Cao J, Okuda S, Ōmura S . Purpactins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Penicillium purpurogenum_. I. Production, isolation
and physico-chemical and biological properties. _J Antibiot_ 44: 136–143 ( 1991) Article CAS Google Scholar * Nishida H, Tomoda H, Cao J, Okuda S, Ōmura S . Purpactins, new inhibitors of
acyl-CoA : cholesterol acyltransferase produced by _Penicillium purpurogenum_. II. Structure elucidation of purpactins A, B and C. _J Antibiot_ 44: 144–151 ( 1991) Article CAS Google
Scholar * Tomoda H, Huang XH, Nishida H, Masuma R, Kim YK, Ōmura S . Glisoprenins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Gliocladium_ sp. FO-1513. I.
Production, isolation and physico-chemical and biological properties. _J Antibiot_ 45: 1202–1206 ( 1992) Article CAS Google Scholar * Nishida H, Huang XH, Tomoda H, Ōmura S .
Glisoprenins, new inhibitors of acyl-CoA : cholesterol acyltransferase produced by _Gliocladium_ sp. FO-1513. II. Structure elucidation of glisoprenins A and B. _J Antibiot_ 45: 1669–1676 (
1992) Article CAS Google Scholar * Ghosh I, Kishi Y, Tomoda H, Ōmura S . Guse of achiral praseodymium shift reagent in predicting the complete stereostructure of glisoprenin A. _Org Lett_
6: 4719–4722 ( 2004) Article CAS PubMed Google Scholar * Huang XH, Tomoda H, Nishida H, Masuma R, Ōmura S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. I.
Production, isolation and biological properties. _J Antibiot_ 48: 1–4 ( 1995) Article CAS Google Scholar * Huang XH, Nishida H, Tomoda H, Tabata N, Shiomi K, Yang DJ, Takayanagi H, Ōmura
S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. II. Structure elucidation of terpendoles A, B, C and D. _J Antibiot_ 48: 5–11 ( 1995) Article CAS Google
Scholar * Tomoda H, Tabata N, Yang DJ, Takayanagi H, Ōmura S . Terpendoles, novel ACAT inhibitors produced by _Albophoma yamanashiensis_. III. Production, isolation and structure
elucidation of new components. _J Antibiot_ 48: 793–804 ( 1995) Article CAS Google Scholar * Namatame I, Tomoda H, Si S, Yamaguchi Y, Masuma R, Ōmura S . Beauveriolides, specific
inhibitors of lipid droplet formation in mouse macrophages, produced by _Beauveria_ sp. FO-6979. _J Antibiot_ 52: 1–6 ( 1999) Article CAS Google Scholar * Namatame I, Tomoda H, Tabata N,
Si S, Ōmura S . Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages. _J Antibiot_ 52: 7–12 ( 1999) Article CAS Google
Scholar * Matsuda D, Namatame I, Tomoda H, Kobayashi S, Zocher R, Kleinkauf H, Ōmura S . New beauveriolide produced by amino acid-supplemented fermentation of _Beauveria_ sp. FO-6979. _J
Antibiot_ 57: 1–9 ( 2004) Article CAS Google Scholar * Mochizuki K, Ohmori K, Tamura H, Shizuri H, Nishiyama S, Miyoshi E, Yamamura S . The structures of bioactive cyclodepsipeptides,
beauveriolides I and II, metabolites of entomopathogenic fungi _Beauveria_ sp. _Bull Chem Soc Jpn_ 66: 3041–3046 ( 1993) Article CAS Google Scholar * Tomoda H, Namatame I, Si S, Kawaguchi
K, Masuma R, Namikoshi M, Ōmura S . Phenochalasins, inhibitors of lipid droplet formation in mouse macrophages, produced by _Phomopsis_ sp. FT-0211. _J Antibiot_ 52: 851–856 ( 1999) Article
CAS Google Scholar * Tomoda H, Namatame I, Tabata N, Kawaguchi K, Si S, Ōmura S . Structure elucidation of fungal phenochalasins, novel inhibitors of lipid droplet formation in mouse
macrophages. _J Antibiot_ 52: 857–861 ( 1999) Article CAS Google Scholar * Koyama N, Nagahiro T, Yamaguchi Y, Ohshiro T, Masuma R, Tomoda H, Ōmura S . Spylidone, a novel inhibitor of
lipid droplet accumulation in mouse macrophages produced by _Phoma_ sp. FKI-1840. _J Antibiot_ 58: 338–345 ( 2005) Article CAS Google Scholar * Uchida R, Kim YP, Namatame I, Tomoda H,
Ōmura S . Sespendole, a new inhibitor of lipid droplet synthesis in macrophages, produced by _Pseudobotrytis terrestris_ FKA-25. _J Antibiot_ 59: 93–97 ( 2006) Article CAS Google Scholar
* Namatame I, Tomoda H, Matsuda D, Tabata N, Kobayashi S, Ōmura S . K97-0239A and B, new inhibitors of macrophage foam cell formation, produced by _Streptomyces_ sp. K97-0239. _Proc Japan
Acad B_ 78: 45–50 ( 2002) Article Google Scholar * Namatame I, Tomoda H, Ishibashi S, Ōmura S . Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation
in macrophages. _Proc Natl Acad Sci USA_ 101: 737–742 ( 2004) Article CAS PubMed PubMed Central Google Scholar * _Chem Eng News_ 18: 15 ( 2004) * Namatame I, Tomoda H, Arai H, Inoue K,
Ōmura S . Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C. _J Biochem_ 25: 319–327 ( 1999) Article Google Scholar * Bligh EG, Dyer W . A rapid method of
total lipid extraction and purification. _Can J Biochem Physiol_ 37: 911–917 ( 1959) Article CAS PubMed Google Scholar * Field FJ, Cooper AD, Erickson SK . Regulation of rabbit
intestinal acyl coenzyme A-cholesterol acyltransferase _in vivo_ and _in vitro_. _Gastroenterology_ 83: 873–880 ( 1982) CAS PubMed Google Scholar * Cho KH, An S, Lee WS, Paik YK, Kim YK,
Jeong TS . Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. _Biochem Biophys Res Commun_ 309:
864–872 ( 2003) Article CAS PubMed Google Scholar * Tomoda H, Namatame I, Ōmura S . Microbial metabolites with inhibitory activity against lipid metabolism. _Proc Japan Acad B_ 78:
217–240 ( 2002) Article Google Scholar * Kouri K, Lemmens M, Gruber RL . Beauvericin-induced channenls in ventricular myocytes and liposomes. _Biochim Biophys Acta_ 1609: 203–210 ( 2003)
Article CAS PubMed Google Scholar * Jow GM, Chou CJ, Chen BF, Tsai JH . Beauvericin induces cytotoxic effects in human acute lympoblastic leukemia cells through cytochrome c release,
caspase 3 activation: the causative role of calcium. _Cancer Lett_ 216: 165–173 ( 2004) Article CAS PubMed Google Scholar * Fukuda T, Arai M, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S .
New beauvericins, potentiators of antifungal miconazole activity, produced by _Beauveria_ sp. FKI-1366. I. _Taxonomy, fermentation, isolation and biological properties, J Antibiot_ 57:
110–116 ( 2004) CAS Google Scholar * Lin S, Cheng D, Liu MS, Chen J, Chang TY . Human acyl-CoA : cholesterol acyltransferase-1 in the endoplasmic reticulum contains seven transmembarane
domains. _J Biol Chem_ 274: 23276–23285 ( 1999) Article CAS PubMed Google Scholar * Joyce CW, Shelness GS, Davis MA, Lee RG, Skinner K, Anderson RA, Rudel LL . ACAT1 and ACAT2 membrane
topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. _Mol Biol Cell_ 11: 3675–3687 ( 2000) Article CAS PubMed PubMed
Central Google Scholar * Guo ZY, Lin S, Heinen JA, Chang CC, Chang TY . The active site His-460 of Human acyl-coenzyme A : cholesterol acyltransferase 1 resides in a hitherto undisclosed
transmembrane domain. _J Biol Chem_ 280: 37814–37826 ( 2005) Article CAS PubMed Google Scholar * Lin S, Lu X, Chang CC, Chang TY . Human acyl-coenzyme A : cholesterol acyltransferase
expressed in Chinese hamuster ovary cells: Membrane topology and active site location. _Mol Biol Cell_ 14: 2447–2460 ( 2003) Article CAS PubMed PubMed Central Google Scholar Download
references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan Hiroshi Tomoda * Kitasato Institute for
Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan Taichi Ohshiro & Satoshi Ōmura * Atherosclerosis
Research Program, Wake Forest University School of Medicine, Winston-Salem, 27157, NC, USA Lawrence L Rudel Authors * Taichi Ohshiro View author publications You can also search for this
author inPubMed Google Scholar * Lawrence L Rudel View author publications You can also search for this author inPubMed Google Scholar * Satoshi Ōmura View author publications You can also
search for this author inPubMed Google Scholar * Hiroshi Tomoda View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to
Hiroshi Tomoda. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Ohshiro, T., Rudel, L., Ōmura, S. _et al._ Selectivity of Microbial Acyl-CoA :
cholesterol Acyltransferase Inhibitors toward Isozymes. _J Antibiot_ 60, 43–51 (2007). https://doi.org/10.1038/ja.2007.6 Download citation * Received: 12 September 2006 * Accepted: 21
December 2006 * Issue Date: 01 January 2007 * DOI: https://doi.org/10.1038/ja.2007.6 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get
shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * acyl-CoA
: cholesterol acyltransferase * isozyme * microbial inhibitors * lipid droplet accumulation * pyripyropene * beauveriolide * atherosclerosis